» Articles » PMID: 1356616

Frequent Loss of Heterozygosity for Loci on Chromosome 8p in Hepatocellular Carcinoma, Colorectal Cancer, and Lung Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 1992 Oct 1
PMID 1356616
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Frequent loss of heterozygosity at chromosomal loci in a specific tumor type may indicate the presence of a tumor suppressor gene. We have examined loss of heterozygosity on chromosome 8p in paired tumor and constitutional DNA from 346 patients representing seven different types of human cancer. Frequent allelic losses were observed in hepatocellular carcinoma (22 of 46 cases, 47.8%), in colorectal cancer (12 of 26, 46.2%), and in non-small cell lung cancer (14 of 35, 40.0%), in contrast to low frequencies detected in breast cancer (5 of 56, 8.9%) and renal cell carcinoma (2 of 27, 7.4%). Ovarian cancer and gastric cancer showed intermediate frequencies of 33.3% and 22.2%. Subsequent analysis of 120 hepatocellular carcinomas and 94 colorectal cancers with five polymorphic markers along the short arm of chromosome 8 defined commonly deleted regions within the same chromosomal interval, 8p23. 1-8p21.3, suggesting that one or more tumor suppressor genes for both cancers may be present in that region.

Citing Articles

Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.

Liang W, Yang X, Li X, Wang P, Zhu Z, Liu S Aging (Albany NY). 2024; 16(9):7596-7621.

PMID: 38742936 PMC: 11131999. DOI: 10.18632/aging.205763.


Establishment and characterization of a highly metastatic hepatocellular carcinoma cell line.

Huang J, Sun M, Wang M, Yu A, Zheng H, Bu C Bioengineered. 2024; 15(1):2296775.

PMID: 38184822 PMC: 10773622. DOI: 10.1080/21655979.2023.2296775.


Tumor Suppressor LncRNA on Chromosome 8p12 (TSLNC8): A Concise Review in Human Malignancies.

Li X, Huang H, Liu M, Luo H J Cancer. 2023; 14(15):2867-2877.

PMID: 37781073 PMC: 10539563. DOI: 10.7150/jca.87801.


Diffusion-Weighted MRI for Treatment Response Assessment in Osteoblastic Metastases-A Repeatability Study.

Eveslage M, Rassek P, Riegel A, Maksoud Z, Bauer J, Gorlich D Cancers (Basel). 2023; 15(15).

PMID: 37568573 PMC: 10417276. DOI: 10.3390/cancers15153757.


TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway.

Sun F, Jie Q, Li Q, Wei Y, Li H, Yue X J Cell Mol Med. 2022; 26(5):1629-1642.

PMID: 35137520 PMC: 8899155. DOI: 10.1111/jcmm.17204.